Generalizability of the Results and Concerns About Leakage Rates of the ICAN Trial

JAMA Surg. 2022 Feb 1;157(2):176. doi: 10.1001/jamasurg.2021.5263.

Authors

Wobbe O de Steur¹, Merlijn Hutteman^{1

2}, Henk H Hartgrink¹

Affiliations

¹ Department of Surgical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
² Department of Thoracic Surgery, Leiden University Medical Center, Leiden, the Netherlands.

PMID: 34668941
DOI: 10.1001/jamasurg.2021.5263

No abstract available

Publication types

Comment